|
1
|
Kansara M, Teng MW, Smyth MJ and Thomas
DM: Translational biology of osteosarcoma. Nat Rev Cancer.
14:722–735. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Geller DS and Gorlick R: Osteosarcoma: A
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.PubMed/NCBI
|
|
3
|
Xiong Y, Wu S, Du Q, Wang A and Wang Z:
Integrated analysis of gene expression and genomic aberration data
in osteosarcoma (OS). Cancer Gene Ther. 22:524–529. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yuan W, Wang D, Liu Y, Tian D, Wang Y,
Zhang R, Yin L and Deng Z: miR-494 inhibits cell proliferation and
metastasis via targeting of CDK6 in osteosarcoma. Mol Med Rep.
16:8627–8634. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang Z, Li X, Yang Y, He Z, Qu X and Zhang
Y: Long noncoding RNAs in the progression, metastasis, and
prognosis of osteosarcoma. Cell Death Dis. 7:e23892016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ivey KN and Srivastava D: MicroRNAs as
regulators of differentiation and cell fate decisions. Cell Stem
Cell. 7:36–41. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao X, Li S, Li W, Wang G, Zhao W, Han J,
Diao C, Wang X and Zhang M: MicroRNA-539 suppresses tumor cell
growth by targeting the WNT8B gene in non-small cell lung cancer. J
Cell Biochem. Dec 21–2017.(Epub ahead of print).
|
|
9
|
Shentu TP, Huang TS, Cernelc-Kohan M, Chan
J, Wong SS, Espinoza CR, Tan C, Gramaglia I, van der Heyde H, Chien
S and Hagood JS: Thy-1 dependent uptake of mesenchymal stem
cell-derived extracellular vesicles blocks myofibroblastic
differentiation. Sci Rep. 7:180522017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang G, Pan J, Ye Z, Fang B, Cheng W and
Cao Z: Overexpression of miR-216b sensitizes NSCLC cells to
cisplatin-induced apoptosis by targeting c-Jun. Oncotarget.
8:104206–104215. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cesarini V, Silvestris DA, Tassinari V,
Tomaselli S, Alon S, Eisenberg E, Locatelli F and Gallo A:
ADAR2/miR-589-3p axis controls glioblastoma cell
migration/invasion. Nucleic Acids Res. 46:2045–2059. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang S, Jin J, Tian X and Wu L:
hsa-miR-29c-3p regulates biological function of colorectal cancer
by targeting SPARC. Oncotarget. 8:104508–104524. 2017.PubMed/NCBI
|
|
14
|
Ye Y, Zhuang J, Wang G, He S, Ni J and Xia
W: MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid
carcinoma progression. Oncol Lett. 14:7799–7806. 2017.PubMed/NCBI
|
|
15
|
Romano G and Kwong LN: Diagnostic and
therapeutic applications of miRNA-based strategies to cancer
immunotherapy. Cancer Metastasis Rev. 37:45–53. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qadir MI and Faheem A: miRNA: A diagnostic
and therapeutic tool for pancreatic cancer. Crit Rev Eukaryot Gene
Expr. 27:197–204. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ou C, Sun Z, Li X, Li X, Ren W, Qin Z,
Zhang X, Yuan W, Wang J, Yu W, et al: miR-590-5p, a
density-sensitive microRNA, inhibits tumorigenesis by targeting
YAP1 in colorectal cancer. Cancer Lett. 399:53–63. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou L, Zhao LC, Jiang N, Wang XL, Zhou
XN, Luo XL and Ren J: MicroRNA miR-590-5p inhibits breast cancer
cell stemness and metastasis by targeting SOX2. Eur Rev Med
Pharmacol Sci. 21:87–94. 2017.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Zhang L, Zhang G, Li S, Duan J,
Cheng J, Ding G, Zhou C, Zhang J, Luo P, et al: Osteosarcoma
metastasis: Prospective role of ezrin. Tumour Biol. 35:5055–5059.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li SL, Gao HL, Lv XK, Hei YR, Li PZ, Zhang
JX and Lu N: MicroRNA-124 inhibits cell invasion and
epithelial-mesenchymal transition by directly repressing Snail2 in
gastric cancer. Eur Rev Med Pharmacol Sci. 21:3389–3396.
2017.PubMed/NCBI
|
|
23
|
Song YX, Sun JX, Zhao JH, Yang YC, Shi JX,
Wu ZH, Chen XW, Gao P, Miao ZF and Wang ZN: Non-coding RNAs
participate in the regulatory network of CLDN4 via ceRNA mediated
miRNA evasion. Nat Commun. 8:2892017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai W, Jiang H, Yu Y, Xu Y, Zuo W, Wang S
and Su Z: miR-367 regulation of DOC-2/DAB2 interactive protein
promotes proliferation, migration and invasion of osteosarcoma
cells. Biomed Pharmacother. 95:120–128. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cui C and Shi X: miR-187 inhibits tumor
growth and invasion by directly targeting MAPK12 in osteosarcoma.
Exp Ther Med. 14:1045–1050. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang B, Li Y, Hou D, Shi Q, Yang S and Li
Q: MicroRNA-375 inhibits growth and enhances radiosensitivity in
oral squamous cell carcinoma by targeting insulin like growth
factor 1 receptor. Cell Physiol Biochem. 42:2105–2117. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim CW, Oh ET, Kim JM, Park JS, Lee DH,
Lee JS, Kim KK and Park HJ: Hypoxia-induced microRNA-590-5p
promotes colorectal cancer progression by modulating matrix
metalloproteinase activity. Cancer Lett. 416:31–41. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma D, Chang LY, Zhao S, Zhao JJ, Xiong YJ,
Cao FY, Yuan L, Zhang Q, Wang XY, Geng ML, et al: KLF5 promotes
cervical cancer proliferation, migration and invasion in a manner
partly dependent on TNFRSF11a expression. Sci Rep. 7:156832017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang T, Chen M, Yang X, Zhang X, Zhang Z,
Sun Y, Xu B, Hua J, He Z and Song Z: Down-regulation of KLF5 in
cancer-associated fibroblasts inhibit gastric cancer cells
progression by CCL5/CCR5 axis. Cancer Biol Ther. 18:806–815. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou W, Song F, Wu Q, Liu R, Wang L, Liu
C, Peng Y, Mao S, Feng J and Chen C: miR-217 inhibits
triple-negative breast cancer cell growth, migration, and invasion
through targeting KLF5. PLoS One. 12:e01763952017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu JY, Lu JB and Xu Y: MicroRNA-153
inhibits the proliferation and invasion of human laryngeal squamous
cell carcinoma by targeting KLF5. Exp Ther Med. 11:2503–2508. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ji Q, Xu X, Li L, Goodman SB, Bi W, Xu M,
Xu Y, Fan Z, Maloney WJ, Ye Q and Wang Y: miR-216a inhibits
osteosarcoma cell proliferation, invasion and metastasis by
targeting CDK14. Cell Death Dis. 8:e31032017. View Article : Google Scholar : PubMed/NCBI
|
